Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: further data.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Epilepsy & Behavior

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.yebeh.2016.10.033PMID 28109779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sleep quality and daytime sleepiness in patients treated with adjunctive perampanel for focal seizures.

  2016cited by this paper
• Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial

  2016cited by this paper
• Normative data for the Montreal Cognitive Assessment in an Italian population sample

  2015cited by this paper
• Effects of epilepsy treatment on sleep architecture and daytime sleepiness: An evidence‐based review of objective sleep metrics

  2014cited by this paper
• Effects of epilepsy treatments on sleep architecture and daytime sleepiness: An evidence‐based review of objective sleep metrics

  2014cited by this paper
• Validity of the Italian Version of the Pittsburgh Sleep Quality Index (PSQI)

  2013cited by this paper
• Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study.

  2013cited by this paper
• Sleep and Epilepsy

  2013cited by this paper
• Epilepsy, Antiseizure Therapy, and Sleep Cycle Parameters

  2013cited by this paper
• Sleep disturbances in people with epilepsy; prevalence, impact and treatment.

  2011cited by this paper
• Pregabalin as add‐on therapy induces REM sleep enhancement in partial epilepsy: a polysomnographic study

  2009cited by this paper
• Italian version of the Epworth sleepiness scale: external validity

  2003cited by this paper
• The identification of depression and the coverage of antidepressant drug prescriptions in Italian general practice.

  2002cited by this paper

• Effectiveness of perampanel as the only adjunctive anti‐seizure medication in adults: Final results from the observational PERPRISE study in Germany

  2025cites this paper
• The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy

  2023cites this paper
• The safety of perampanel in different disorders and doses: A meta-analysis.

  2023cites this paper
• Sleep macrostructure and cyclic alternating pattern in patients who underwent surgery for hippocampal sclerosis: A prospective controlled polysomnographic study.

  2022cites this paper
• Sleep–wake cycle and daytime sleepiness in patients with epilepsy after initiating perampanel as adjunctive therapy

  2022cites this paper
• Effects of anti-seizure medications on sleep architecture and daytime sleepiness in patients with epilepsy: A literature review.

  2021cites this paper
• A Severe Dementia Case in End of Life Care with Psychiatric Symptoms Treated by Perampanel

  2021cites this paper
• Expert Opinion: Managing sleep disturbances in people with epilepsy.

  2021cites this paper
• The impact of perampanel on cognition: A systematic review of studies employing standardized tests in patients with epilepsy.

  2021cites this paper
• The use of perampanel in drug-resistant focal epilepsy: its effect on sleep

  2020cites this paper
• Effects of eslicarbazepine as add-on therapy on sleep architecture in temporal lobe epilepsy: results from "Esleep" study.

  2020cites this paper
• Insomnia is less prevalent and less severe, independent of depressive symptoms, in patients with epilepsy treated with perampanel as an adjuvant.

  2020cites this paper
• Perampanel Increases Cortical EEG Fast Activity in Child and Adult Patients Affected by Epilepsy: A Quantitative EEG Study

  2020cites this paper
• Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC‐611), a selective antagonist of TARP‐&ggr;8‐associated AMPA receptors

  2017cites this paper